Supply of AmpliSeq Transcriptome Reagents

The contract involves the supply of Ion AmpliSeq Transcriptome reagents alongside associated sequencing kits intended for transcriptomic analysis of blood samples collected from patients diagnosed with Alcohol Use Disorder as well as from control subjects. The materials supplied must be specifically compatible with low-input and degraded RNA samples, ensuring reliable results even when sample quality is compromised. This subcontract is to be performed in Rockville, with the National Institutes of Health under the Department of Health and Human Services serving as the issuing agency. The procurement is classified under NAICS code 325414, which pertains to pharmaceutical preparation manufacturing. The solicitation does not specify a set-aside type, and the response deadline is set for June 25, 2026, shortly after the contract posting date of June 16, 2026. The focus on specialized reagents for transcriptomic assays indicates the contract's role in supporting advanced biomedical research, particularly in understanding gene expression changes associated with Alcohol Use Disorder using state-of-the-art sequencing technologies.